The induction of inflammation in AF and NP cells after treatment with IL-1β was confirmed by detecting a significant increase in IL-6 secretion compared to untreated cells, though high variability in inflammatory response was observed between donors (Fig. 1j). Here, IL6 is linked to atrial fibrillation.